What is the appropriate management for a patient experiencing nighttime anxiety with insomnia and palpitations for over a month without any specific worry?

Management of Nighttime Anxiety with Insomnia and Palpitations

You should start cognitive behavioral therapy for insomnia (CBT-I) immediately, as this is the first-line treatment for chronic insomnia even when anxiety symptoms are present, and recent evidence shows treating insomnia directly is more effective than treating anxiety alone when both conditions coexist 1, 2.

Initial Clinical Assessment

Before proceeding with treatment, you need to rule out medical causes of palpitations and nighttime awakening:

• Cardiac evaluation: Given the pounding heart symptoms, obtain an ECG and consider Holter monitoring to exclude arrhythmias, especially if palpitations are prominent
• Thyroid function: Hyperthyroidism commonly presents with anxiety, insomnia, and palpitations
• Caffeine and substance use: Quantify daily caffeine intake and timing, assess for alcohol or stimulant use
• Medication review: Check if any current medications could cause insomnia or anxiety
• Sleep disorders: Screen for obstructive sleep apnea, which can present with nighttime awakenings and anxiety symptoms

Treatment Algorithm

First-Line: Cognitive Behavioral Therapy for Insomnia (CBT-I)

The American College of Physicians provides a strong recommendation that CBT-I should be the initial treatment for chronic insomnia (symptoms ≥3 nights/week for ≥3 months) 1. The American Academy of Sleep Medicine reinforces this as the primary behavioral intervention 3.

Why CBT-I over anxiety treatment? A 2023 randomized controlled trial directly compared internet-based CBT for insomnia versus CBT for anxiety in patients with both conditions. The insomnia treatment was more effective at reducing insomnia symptoms AND equally effective at reducing anxiety symptoms 2. This means treating the insomnia directly addresses both problems simultaneously.

CBT-I components include:

• Sleep restriction therapy (limiting time in bed to actual sleep time)
• Stimulus control (bed only for sleep, not worry)
• Cognitive therapy (addressing anxious thoughts about sleep)
• Sleep hygiene education (though not effective alone)

Delivery options:

• In-person individual or group therapy (most effective)
• Internet-based programs (proven effective in the research)
• Telephone-based modules
• Self-help books (least effective but better than nothing)

Expected timeline: Improvements are gradual over 4-8 sessions, not immediate like medications. Set this expectation upfront to prevent early discontinuation 3.

Second-Line: Pharmacotherapy (If CBT-I Insufficient)

The guidelines recommend using shared decision-making to add short-term pharmacotherapy only after CBT-I has been attempted 1. However, given the severity and duration (>1 month), you may consider concurrent initiation.

For comorbid insomnia and anxiety, evidence-supported options include:

• Eszopiclone: Has specific evidence for both generalized anxiety disorder and depression-related insomnia 4
• Zolpidem: Supported for generalized anxiety disorder with insomnia 4
• Dual orexin receptor antagonists (DORAs): Suvorexant, lemborexant, or daridorexant
  • These inhibit wakefulness rather than sedate
  • No rebound insomnia or withdrawal
  • Minimal abuse potential
  • Daridorexant has ideal 8-hour half-life and 12-month efficacy data 5

Avoid as first-line:

• Benzodiazepines: Despite being commonly prescribed (55-70% in some settings), they are NOT guideline-recommended first-line therapy 6, 7
• Antihistamines: Limited efficacy evidence
• Sleep hygiene alone: Ineffective as monotherapy 3

Critical Pitfalls to Avoid

1. Don't assume insomnia is "secondary" to anxiety: The relationship is bidirectional and complex. Both conditions require independent treatment attention 8. Treating only the anxiety will likely leave the insomnia unresolved.

2. Don't prescribe benzodiazepines reflexively: Despite their widespread use (40% of psychiatric inpatients), they are not guideline-concordant first-line therapy and carry significant risks 6.

3. Don't delay CBT-I waiting for medication to work: The evidence clearly shows CBT-I produces durable benefits beyond treatment end, while medications often lead to dependence 3.

4. Don't ignore the palpitations: While anxiety can cause palpitations, you must exclude cardiac and endocrine causes before attributing everything to anxiety.

When Both Conditions Persist

If symptoms continue despite CBT-I, recognize this as comorbid insomnia and anxiety disorder, not secondary insomnia. Both conditions need targeted treatment 8:

• Continue CBT-I
• Add pharmacotherapy (eszopiclone or DORA preferred)
• Consider adding anxiety-specific treatment (SSRI/SNRI) if anxiety symptoms remain prominent despite improved sleep
• Low-dose doxepin (tricyclic antidepressant) is FDA-approved for insomnia and may address both conditions 5

The key insight from recent research: treating insomnia first is the most efficient strategy when both conditions coexist 2. This approach improves both sleep and anxiety symptoms simultaneously, making it superior to treating anxiety alone.